Dr. Sandy Reyna, Head-Therapeutic Area at Novartis Gene Therapies and Kathryn McBride, parent of child with SMA: The Importance of early dia

A year and a half ago, a family received a devastating diagnosis in the midst of the onset of the COVID-19 pandemic. Today, that mother is sharing her son’s experience with (SMA), a rare, devastating genetic disease that is also a leading genetic cause of infant death, and how early diagnosis and treatment transformed his life. My guests are Dr. Sandy Reyna, Vice President of Global Medical Affairs, Head-Therapeutic Area at Novartis Gene Therapies and Kathryn McBride, parent of child with SMA. We talk about the signs of SMA, the importance of newborn screening and an early diagnosis, and new treatment options.